Asparagus cochinchinensis alleviates disturbances of lipid metabolism and gut microbiota in high-fat diet-induced obesity mice

Shiyue Luo,Lixiao Zhou,Xuejun Jiang,Yinyin Xia,Lishuang Huang,Run Ling,Shixin Tang,Zhen Zou,Chengzhi Chen,Jingfu Qiu
DOI: https://doi.org/10.3389/fphar.2022.1015005
IF: 5.6
2022-10-13
Frontiers in Pharmacology
Abstract:Asparagus cochinchinensis is a valuable traditional Chinese medicine that has anti-inflammatory ability and effectively regulates the dysbiosis within the body. Obesity is usually characterized by chronic low-grade inflammation with aberrant gut microbiota. However, the role of Asparagus cochinchinensis against obesity remains unknown. Therefore, a high-fat diet (HFD)-induced obese mouse model with or without aqueous extract from Asparagus cochinchinensis root (ACE) treatment was established herein to determine whether ACE alleviated obesity and its involved mechanisms. Our results showed that ACE root administration significantly decreased the weight gain and relieved dyslipidemia induced by high-fat diet. Treatment of ACE root also improved glucose tolerance and insulin resistance in obese animal model, and remarkably decreased inflammation and lipogenesis in the liver and adipose. Moreover, administration of ACE root significantly reshaped the gut microbiota of obese mice. These findings together suggest that ACE root has beneficial effect against HFD-induced obesity and will provide valuable insights for the therapeutic potential of ACE against obesity and may aid in strategy-making for weight loss.
pharmacology & pharmacy
What problem does this paper attempt to address?